Replication-defective vector based on a chimpanzee adenovirus

被引:215
作者
Farina, SF
Gao, GP
Xiang, ZQ
Rux, JJ
Burnett, RM
Alvira, MR
Marsh, J
Ertl, HCJ
Wilson, JM
机构
[1] Univ Penn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA
[3] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/JVI.75.23.11603-11613.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An adenovirus previously isolated from a mesenteric lymph node from a chimpanzee was fully sequenced and found to be similar in overall structure to human adenoviruses. The genome of this virus, called C68, is 36,521 bp in length and is most similar to subgroup E of human adenovirus, with 90% identity in most adenovirus type 4 open reading frames that have been sequenced. Substantial differences in the hexon hypervariable regions were noted between C68 and other known adenoviruses, including adenovirus type 4. Neutralizing antibodies to C68 were highly prevalent in sera from a population of chimpanzees, while sera from humans and rhesus monkeys failed to neutralize C68. Furthermore, infection with C68 was not neutralized from sera of mice immunized with human adenovirus serotypes 2, 4, 5, 7, and 12. A replication-defective version of C68 was created by replacing the E1a and E1b genes with a minigene cassette; this vector was efficiently transcomplemented by the E1 region of human adenovirus type 5. C68 vector transduced a number of human and murine cell lines. This nonhuman adenoviral vector is sufficiently similar to human serotypes to allow growth in 293 cells and transduction of cells expressing the coxsackievirus and adenovirus receptor. As it is dissimilar in regions such as the hexon hypervariable domains, C68 vector avoids significant cross-neutralization by sera directed against human serotypes.
引用
收藏
页码:11603 / 11613
页数:11
相关论文
共 39 条
  • [1] THE REFINED CRYSTAL-STRUCTURE OF HEXON, THE MAJOR COAT PROTEIN OF ADENOVIRUS TYPE-2, AT 2-CENTER-DOT-9 ANGSTROM RESOLUTION
    ATHAPPILLY, FK
    MURALI, R
    RUX, JJ
    CAI, ZP
    BURNETT, RM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 242 (04) : 430 - 455
  • [2] Subgroup B adenovirus type 35 early region 3 mRNAs differ from those of the subgroup C adenoviruses
    Basler, CF
    Horwitz, MS
    [J]. VIROLOGY, 1996, 215 (02) : 165 - 177
  • [3] CHARACTERIZATION OF 4 NEW ADENOVIRUS SEROTYPES ISOLATED FROM CHIMPANZEE TISSUE EXPLANTS
    BASNIGHT, M
    ROGERS, NG
    GIBBS, CJ
    GAJDUSEK, DC
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1971, 94 (02) : 166 - &
  • [4] GENERATION OF ADENOVIRUS BY TRANSFECTION OF PLASMIDS
    BERKNER, KL
    SHARP, PA
    [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (17) : 6003 - 6020
  • [5] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [6] Immune responses to adenovirus and adeno-associated virus in humans
    Chirmule, N
    Propert, KJ
    Magosin, SA
    Qian, Y
    Qian, R
    Wilson, JM
    [J]. GENE THERAPY, 1999, 6 (09) : 1574 - 1583
  • [7] Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products
    Christ, M
    Louis, B
    Stoeckel, F
    Dieterle, A
    Grave, L
    Dreyer, D
    Kintz, J
    Hadji, DA
    Lusky, M
    Mehtali, M
    [J]. HUMAN GENE THERAPY, 2000, 11 (03) : 415 - 427
  • [8] Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues
    CrawfordMiksza, L
    Schnurr, DP
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1836 - 1844
  • [9] High throughput method for creating and screening recombinant adenoviruses
    Davis, AR
    Meyers, K
    Wilson, JM
    [J]. GENE THERAPY, 1998, 5 (08) : 1148 - 1152
  • [10] Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses
    Dedieu, JF
    Vigne, E
    Torrent, C
    Jullien, C
    Mahfouz, I
    Caillaud, JM
    Aubailly, N
    Orsini, C
    Guillaume, JM
    Opolon, P
    Delaere, P
    Perricaudet, M
    Yeh, P
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (06) : 4626 - 4637